JP2023531185A5 - - Google Patents
Info
- Publication number
- JP2023531185A5 JP2023531185A5 JP2022577477A JP2022577477A JP2023531185A5 JP 2023531185 A5 JP2023531185 A5 JP 2023531185A5 JP 2022577477 A JP2022577477 A JP 2022577477A JP 2022577477 A JP2022577477 A JP 2022577477A JP 2023531185 A5 JP2023531185 A5 JP 2023531185A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063040894P | 2020-06-18 | 2020-06-18 | |
| US63/040,894 | 2020-06-18 | ||
| US202163166062P | 2021-03-25 | 2021-03-25 | |
| US63/166,062 | 2021-03-25 | ||
| PCT/US2021/037364 WO2021257525A1 (en) | 2020-06-18 | 2021-06-15 | Conditionally active anti-nectin-4 antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023531185A JP2023531185A (ja) | 2023-07-21 |
| JPWO2021257525A5 JPWO2021257525A5 (https=) | 2024-06-18 |
| JP2023531185A5 true JP2023531185A5 (https=) | 2024-06-18 |
Family
ID=79268274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022577477A Pending JP2023531185A (ja) | 2020-06-18 | 2021-06-15 | 条件的に活性な抗ネクチン４抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230235054A1 (https=) |
| EP (1) | EP4168453A4 (https=) |
| JP (1) | JP2023531185A (https=) |
| KR (1) | KR20230038711A (https=) |
| CN (1) | CN115768798A (https=) |
| AU (1) | AU2021293183A1 (https=) |
| CA (1) | CA3182395A1 (https=) |
| IL (1) | IL298903A (https=) |
| MX (1) | MX2022016192A (https=) |
| TW (1) | TWI901704B (https=) |
| WO (1) | WO2021257525A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021213421B2 (en) | 2020-01-31 | 2025-02-06 | Innate Pharma | Treatment of cancer |
| CA3196198A1 (en) * | 2020-11-25 | 2022-06-02 | Manel KRAIEM | Treatment of cancer |
| CA3226059A1 (en) * | 2021-06-29 | 2023-01-05 | Elpis Biopharmaceuticals | Anti-nectin4 antibodies and multi-specific protein complexes comprising such |
| AU2023208041A1 (en) * | 2022-01-12 | 2024-07-18 | Navi Bio-Therapeutics, Inc. | Antibody specific to nectin cell adhesion molecule 4 and uses thereof |
| CN116063498A (zh) * | 2022-04-27 | 2023-05-05 | 博际生物医药科技(杭州)有限公司 | 单域抗Nectin-4抗体 |
| WO2024012541A1 (zh) * | 2022-07-14 | 2024-01-18 | 百奥泰生物制药股份有限公司 | 抗Nectin-4抗体药物偶联物及应用 |
| JP2025525518A (ja) * | 2022-07-14 | 2025-08-05 | バイオ－テラ ソリュ－ションズ，エルティーディー． | 抗Ｎｅｃｔｉｎ－４抗体、その抗体薬物コンジュゲート及び応用 |
| EP4438624A1 (en) | 2023-03-27 | 2024-10-02 | LAVA Therapeutics N.V. | Antibodies that bind nectin-4 and gamma-delta t cell receptors |
| WO2024200573A1 (en) | 2023-03-27 | 2024-10-03 | LAVA Therapeutics N.V. | Nectin-4 binding agents and methods of use |
| TW202530249A (zh) * | 2023-09-29 | 2025-08-01 | 美商雅克提斯腫瘤學公司 | 小蛋白、結合物及其用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3803790B2 (ja) * | 2003-02-17 | 2006-08-02 | 株式会社東北テクノアーチ | 新規なダイアボディ型二重特異性抗体 |
| US20110301056A1 (en) * | 2008-12-12 | 2011-12-08 | Oncotherapy Science, Inc. | Nectin-4 for target genes of cancer therapy and diagnosis |
| EP3409287B9 (en) * | 2010-09-29 | 2021-07-21 | Agensys, Inc. | Antibody drug conjugates (adc) that bind to 191p4d12 proteins |
| US10675357B2 (en) * | 2015-09-09 | 2020-06-09 | INSERM (Institut National de la Santé et de la Recherche Médicale | Antibodies having specificity to nectin-4 and uses thereof |
| WO2017078839A1 (en) * | 2015-11-02 | 2017-05-11 | Bioatla, Llc | Conditionally active polypeptides |
| KR102873209B1 (ko) * | 2016-08-31 | 2025-10-17 | 바이오아트라, 인코퍼레이티드 | 조건부 활성 폴리펩티드 및 이를 제조하는 방법 |
| CN111675761B (zh) * | 2017-06-05 | 2023-10-20 | 艾更斯司股份有限公司 | 柄蛋白-4结合蛋白及其使用方法 |
| KR102892725B1 (ko) * | 2018-05-09 | 2025-12-01 | 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. | 인간 넥틴4에 특이적인 항체 |
| IL279399B1 (en) * | 2018-06-14 | 2026-04-01 | Bioatla Llc | Multispecific antibody templates |
-
2021
- 2021-06-15 CA CA3182395A patent/CA3182395A1/en active Pending
- 2021-06-15 US US18/002,064 patent/US20230235054A1/en active Pending
- 2021-06-15 JP JP2022577477A patent/JP2023531185A/ja active Pending
- 2021-06-15 IL IL298903A patent/IL298903A/en unknown
- 2021-06-15 MX MX2022016192A patent/MX2022016192A/es unknown
- 2021-06-15 CN CN202180043514.3A patent/CN115768798A/zh active Pending
- 2021-06-15 AU AU2021293183A patent/AU2021293183A1/en active Pending
- 2021-06-15 WO PCT/US2021/037364 patent/WO2021257525A1/en not_active Ceased
- 2021-06-15 EP EP21826366.3A patent/EP4168453A4/en active Pending
- 2021-06-15 KR KR1020237002055A patent/KR20230038711A/ko active Pending
- 2021-06-18 TW TW110122293A patent/TWI901704B/zh active